世界の婦人科がん治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gynecological Cancers Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5764 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、婦人科がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（子宮頸がん、卵巣がん、子宮内膜がん、膣がん、外陰がん、その他）、用途別市場規模（標的療法、化学療法）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・婦人科がん治療薬の市場動向 ・企業の競争状況、市場シェア ・婦人科がん治療薬の種類別市場規模と予測2016-2027（子宮頸がん、卵巣がん、子宮内膜がん、膣がん、外陰がん、その他） ・婦人科がん治療薬の用途別市場規模と予測2016-2027（標的療法、化学療法） ・婦人科がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・婦人科がん治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・婦人科がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・婦人科がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・婦人科がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Bristol-Myers Squibb Company、F. Hoffmann-La Roche Ltd、GlaxoSmithKline plc、Merck & Co., Inc.） ・結論

Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.
The presence of a strong pipeline and new drug approvals are critical reasons that will drive gynecological cancers therapeutics market growth. The pipeline for gynecological cancers treatment includes novel therapeutics such as targeted therapy products, gene therapy, and vaccines. These products are expected to change the course of gynecological cancer treatment as they are associated with advanced therapeutic mechanisms of action. Some of these mechanisms include cell cycle inhibition, angiogenesis inhibition, programmed death-ligand 1 (PD-L1) inhibition, and PARP inhibition. The approval of novel gynecological cancer therapeutics by the US FDA is increasing due to the efficiency of these drugs.

Market Analysis and Insights: Global Gynecological Cancers Therapeutics Market
The global Gynecological Cancers Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gynecological Cancers Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gynecological Cancers Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gynecological Cancers Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gynecological Cancers Therapeutics market.

Global Gynecological Cancers Therapeutics Scope and Market Size
Gynecological Cancers Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gynecological Cancers Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cervical Cancer
Ovarian Cancer
Endometrial Cancer
Vaginal Cancer
Vulvar Cancer
Other

Segment by Application
Targeted Therapy
Chemotherapy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Merck & Co., Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gynecological Cancers Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cervical Cancer
1.2.3 Ovarian Cancer
1.2.4 Endometrial Cancer
1.2.5 Vaginal Cancer
1.2.6 Vulvar Cancer
1.2.7 Other
1.3 Market by Application
1.3.1 Global Gynecological Cancers Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Targeted Therapy
1.3.3 Chemotherapy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gynecological Cancers Therapeutics Market Perspective (2016-2027)
2.2 Gynecological Cancers Therapeutics Growth Trends by Regions
2.2.1 Gynecological Cancers Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gynecological Cancers Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gynecological Cancers Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gynecological Cancers Therapeutics Industry Dynamic
2.3.1 Gynecological Cancers Therapeutics Market Trends
2.3.2 Gynecological Cancers Therapeutics Market Drivers
2.3.3 Gynecological Cancers Therapeutics Market Challenges
2.3.4 Gynecological Cancers Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gynecological Cancers Therapeutics Players by Revenue
3.1.1 Global Top Gynecological Cancers Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gynecological Cancers Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gynecological Cancers Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gynecological Cancers Therapeutics Revenue
3.4 Global Gynecological Cancers Therapeutics Market Concentration Ratio
3.4.1 Global Gynecological Cancers Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gynecological Cancers Therapeutics Revenue in 2020
3.5 Gynecological Cancers Therapeutics Key Players Head office and Area Served
3.6 Key Players Gynecological Cancers Therapeutics Product Solution and Service
3.7 Date of Enter into Gynecological Cancers Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gynecological Cancers Therapeutics Breakdown Data by Type
4.1 Global Gynecological Cancers Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gynecological Cancers Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gynecological Cancers Therapeutics Breakdown Data by Application
5.1 Global Gynecological Cancers Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gynecological Cancers Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gynecological Cancers Therapeutics Market Size (2016-2027)
6.2 North America Gynecological Cancers Therapeutics Market Size by Type
6.2.1 North America Gynecological Cancers Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gynecological Cancers Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gynecological Cancers Therapeutics Market Size by Type (2016-2027)
6.3 North America Gynecological Cancers Therapeutics Market Size by Application
6.3.1 North America Gynecological Cancers Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gynecological Cancers Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gynecological Cancers Therapeutics Market Size by Application (2016-2027)
6.4 North America Gynecological Cancers Therapeutics Market Size by Country
6.4.1 North America Gynecological Cancers Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gynecological Cancers Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gynecological Cancers Therapeutics Market Size (2016-2027)
7.2 Europe Gynecological Cancers Therapeutics Market Size by Type
7.2.1 Europe Gynecological Cancers Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gynecological Cancers Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gynecological Cancers Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gynecological Cancers Therapeutics Market Size by Application
7.3.1 Europe Gynecological Cancers Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gynecological Cancers Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gynecological Cancers Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gynecological Cancers Therapeutics Market Size by Country
7.4.1 Europe Gynecological Cancers Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gynecological Cancers Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gynecological Cancers Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gynecological Cancers Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gynecological Cancers Therapeutics Market Size (2016-2027)
9.2 Latin America Gynecological Cancers Therapeutics Market Size by Type
9.2.1 Latin America Gynecological Cancers Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gynecological Cancers Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gynecological Cancers Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gynecological Cancers Therapeutics Market Size by Application
9.3.1 Latin America Gynecological Cancers Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gynecological Cancers Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gynecological Cancers Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gynecological Cancers Therapeutics Market Size by Country
9.4.1 Latin America Gynecological Cancers Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gynecological Cancers Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gynecological Cancers Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gynecological Cancers Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gynecological Cancers Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gynecological Cancers Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Gynecological Cancers Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancers Therapeutics Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Gynecological Cancers Therapeutics Introduction
11.4.4 GlaxoSmithKline plc Revenue in Gynecological Cancers Therapeutics Business (2016-2021)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Gynecological Cancers Therapeutics Introduction
11.5.4 Merck & Co., Inc. Revenue in Gynecological Cancers Therapeutics Business (2016-2021)
11.5.5 Merck & Co., Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gynecological Cancers Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cervical Cancer
Table 3. Key Players of Ovarian Cancer
Table 4. Key Players of Endometrial Cancer
Table 5. Key Players of Vaginal Cancer
Table 6. Key Players of Vulvar Cancer
Table 7. Key Players of Other
Table 8. Global Gynecological Cancers Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Gynecological Cancers Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Gynecological Cancers Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Gynecological Cancers Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Gynecological Cancers Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Gynecological Cancers Therapeutics Market Share by Regions (2022-2027)
Table 14. Gynecological Cancers Therapeutics Market Trends
Table 15. Gynecological Cancers Therapeutics Market Drivers
Table 16. Gynecological Cancers Therapeutics Market Challenges
Table 17. Gynecological Cancers Therapeutics Market Restraints
Table 18. Global Gynecological Cancers Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Gynecological Cancers Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Gynecological Cancers Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gynecological Cancers Therapeutics as of 2020)
Table 21. Ranking of Global Top Gynecological Cancers Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Gynecological Cancers Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Gynecological Cancers Therapeutics Product Solution and Service
Table 25. Date of Enter into Gynecological Cancers Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gynecological Cancers Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Gynecological Cancers Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Gynecological Cancers Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Gynecological Cancers Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Gynecological Cancers Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Gynecological Cancers Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Gynecological Cancers Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Gynecological Cancers Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Gynecological Cancers Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Gynecological Cancers Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Gynecological Cancers Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Gynecological Cancers Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Gynecological Cancers Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Gynecological Cancers Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Gynecological Cancers Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Gynecological Cancers Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Gynecological Cancers Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Gynecological Cancers Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Gynecological Cancers Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Gynecological Cancers Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gynecological Cancers Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Gynecological Cancers Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Gynecological Cancers Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Gynecological Cancers Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Gynecological Cancers Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Gynecological Cancers Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Gynecological Cancers Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Gynecological Cancers Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Gynecological Cancers Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Gynecological Cancers Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Gynecological Cancers Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Gynecological Cancers Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gynecological Cancers Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Gynecological Cancers Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Gynecological Cancers Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Gynecological Cancers Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Gynecological Cancers Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Gynecological Cancers Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. AstraZeneca Company Details
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Gynecological Cancers Therapeutics Product
Table 68. AstraZeneca Revenue in Gynecological Cancers Therapeutics Business (2016-2021) & (US$ Million)
Table 69. AstraZeneca Recent Development
Table 70. Bristol-Myers Squibb Company Company Details
Table 71. Bristol-Myers Squibb Company Business Overview
Table 72. Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Product
Table 73. Bristol-Myers Squibb Company Revenue in Gynecological Cancers Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Bristol-Myers Squibb Company Recent Development
Table 75. F. Hoffmann-La Roche Ltd Company Details
Table 76. F. Hoffmann-La Roche Ltd Business Overview
Table 77. F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Product
Table 78. F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancers Therapeutics Business (2016-2021) & (US$ Million)
Table 79. F. Hoffmann-La Roche Ltd Recent Development
Table 80. GlaxoSmithKline plc Company Details
Table 81. GlaxoSmithKline plc Business Overview
Table 82. GlaxoSmithKline plc Gynecological Cancers Therapeutics Product
Table 83. GlaxoSmithKline plc Revenue in Gynecological Cancers Therapeutics Business (2016-2021) & (US$ Million)
Table 84. GlaxoSmithKline plc Recent Development
Table 85. Merck & Co., Inc. Company Details
Table 86. Merck & Co., Inc. Business Overview
Table 87. Merck & Co., Inc. Gynecological Cancers Therapeutics Product
Table 88. Merck & Co., Inc. Revenue in Gynecological Cancers Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Merck & Co., Inc. Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gynecological Cancers Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Cervical Cancer Features
Figure 3. Ovarian Cancer Features
Figure 4. Endometrial Cancer Features
Figure 5. Vaginal Cancer Features
Figure 6. Vulvar Cancer Features
Figure 7. Other Features
Figure 8. Global Gynecological Cancers Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Targeted Therapy Case Studies
Figure 10. Chemotherapy Case Studies
Figure 11. Gynecological Cancers Therapeutics Report Years Considered
Figure 12. Global Gynecological Cancers Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Gynecological Cancers Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Gynecological Cancers Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Gynecological Cancers Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Gynecological Cancers Therapeutics Market Share by Players in 2020
Figure 17. Global Top Gynecological Cancers Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gynecological Cancers Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Gynecological Cancers Therapeutics Revenue in 2020
Figure 19. Global Gynecological Cancers Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Gynecological Cancers Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Gynecological Cancers Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Gynecological Cancers Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Gynecological Cancers Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Gynecological Cancers Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Gynecological Cancers Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Gynecological Cancers Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Gynecological Cancers Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Gynecological Cancers Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Gynecological Cancers Therapeutics Market Share by Region (2016-2027)
Figure 41. China Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Gynecological Cancers Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Gynecological Cancers Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Gynecological Cancers Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Gynecological Cancers Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Gynecological Cancers Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Gynecological Cancers Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Gynecological Cancers Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AstraZeneca Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2016-2021)
Figure 61. Bristol-Myers Squibb Company Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2016-2021)
Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2016-2021)
Figure 64. Merck & Co., Inc. Revenue Growth Rate in Gynecological Cancers Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---